(Q37496792)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471850%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

review article

1 reference

title

Recent developments in multiple system atrophy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471850%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471850%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Nadia Stefanova

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471850%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Nadia Stefanova

series ordinal

2

1 reference

20 August 2017

27 May 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471850%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471850%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

256

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471850%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471850%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

1791-1808

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471850%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00415-009-5173-8

29 January 2020

exact match

0 references

cites work

Survival of patients with pathologically proven multiple system atrophy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5173-8

Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5173-8

Subacute systemic 3-nitropropionic acid intoxication induces a distinct motor disorder in adult C57Bl/6 mice: behavioural and histopathological characterisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5173-8

REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5173-8

Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5173-8

Long-term effect of CPAP in the treatment of nocturnal stridor in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5173-8

Microglial activation parallels system degeneration in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5173-8

Myelin degeneration in multiple system atrophy detected by unique antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5173-8

Multiple system atrophy/progressive supranuclear palsy: alpha-Synuclein, synphilin, tau, and APOE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5173-8

Abnormal respiration and sudden death during sleep in multiple system atrophy with autonomic failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5173-8

REM sleep behavior disorders in multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5173-8

Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5173-8

A neurological syndrome associated with orthostatic hypotension: a clinical-pathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5173-8

Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5173-8

Rasagiline alone and in combination with riluzole prolongs survival in an ALS mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-009-5173-8

Epidemiological evidence on multiple system atrophy

21 January 2018

1 reference

12 December 2020

Red flags for multiple system atrophy

1 reference

12 December 2020

No mutation in the entire coding region of the alpha-synuclein gene in pathologically confirmed cases of multiple system atrophy.

1 reference

12 December 2020

Usefulness of combined fractional anisotropy and apparent diffusion coefficient values for detection of involvement in multiple system atrophy

1 reference

12 December 2020

Clinical features and natural history of multiple system atrophy. An analysis of 100 cases.

1 reference

12 December 2020

The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes

1 reference

12 December 2020

Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate].

1 reference

12 December 2020

Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes

1 reference

12 December 2020

Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice

1 reference

12 December 2020

Alpha-1-antichymotrypsin gene polymorphism and susceptibility to multiple system atrophy (MSA)

1 reference

12 December 2020

Pathology and genetics of multiple system atrophy: an approach to determining genetic susceptibility spectrum

1 reference

12 December 2020

Tau immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy

1 reference

12 December 2020

Striatal transplantation in a rodent model of multiple system atrophy: effects on L-Dopa response

1 reference

12 December 2020

Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study.

1 reference

12 December 2020

Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy.

1 reference

12 December 2020

Parkinsonism and nigrostriatal dysfunction are associated with spinocerebellar ataxia type 6 (SCA6).

1 reference

12 December 2020

Pathology of the inferior olivary nucleus in patients with multiple system atrophy.

1 reference

12 December 2020

Rasagiline promotes regeneration of substantia nigra dopaminergic neurons in post-MPTP-induced Parkinsonism via activation of tyrosine kinase receptor signaling pathway

1 reference

12 December 2020

Grading of neuropathology in multiple system atrophy: proposal for a novel scale

1 reference

12 December 2020

The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson's disease: a prospective blinded study

1 reference

12 December 2020

Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease

1 reference

12 December 2020

Norepinephrine precursor therapy in neurogenic orthostatic hypotension

1 reference

12 December 2020

Survival in multiple system atrophy

1 reference

12 December 2020

Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy

1 reference

12 December 2020

Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound

1 reference

12 December 2020

Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients.

1 reference

12 December 2020

Progression of dysautonomia in multiple system atrophy: a prospective study of self-perceived impairment.

1 reference

12 December 2020

Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple system atrophy

1 reference

12 December 2020

Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome).

1 reference

12 December 2020

Neurodegenerative diseases: an overview of environmental risk factors

1 reference

12 December 2020

Autonomic dysfunction in different subtypes of multiple system atrophy.

1 reference

12 December 2020

Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism

1 reference

12 December 2020

How do patients with parkinsonism present? A clinicopathological study

1 reference

12 December 2020

Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study

1 reference

12 December 2020

Multiple system atrophy: a primary oligodendrogliopathy.

1 reference

12 December 2020

Voxel based comparison of glucose metabolism in the differential diagnosis of the multiple system atrophy using statistical parametric mapping

1 reference

12 December 2020

Multiplex families with multiple system atrophy.

1 reference

12 December 2020

Brain magnetic resonance imaging (MRI) in parkinsonian disorders

1 reference

12 December 2020

Botulinum toxin type A for drooling in Parkinson's disease: A double-blind, randomized, placebo-controlled study

1 reference

12 December 2020

Shy-Drager syndrome and amyotrophic lateral sclerosis. Cytoarchitectonic and morphometric studies of sacral autonomic neurons

1 reference

12 December 2020

Parkinson's disease-like presentation of multiple system atrophy with poor response to STN stimulation: a clinicopathological case report.

1 reference

12 December 2020

Second consensus statement on the diagnosis of multiple system atrophy

1 reference

12 December 2020

Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte

1 reference

12 December 2020

How to diagnose MSA early: the role of magnetic resonance imaging

1 reference

12 December 2020

P25alpha immunoreactivity in multiple system atrophy and Parkinson disease.

1 reference

12 December 2020

Placebo-controlled trial of amantadine in multiple-system atrophy.

1 reference

12 December 2020

Severe dysphagia after botulinum toxin injection for cervical dystonia in multiple system atrophy

1 reference

12 December 2020

Multiple system atrophy in a patient with the spinocerebellar ataxia 3 gene mutation.

1 reference

12 December 2020

Early development of autonomic dysfunction may predict poor prognosis in patients with multiple system atrophy.

1 reference

12 December 2020

Environmental— occupational risk factors and familial associations in multiple system atrophy: A preliminary investigation

1 reference

12 December 2020

Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy

1 reference

12 December 2020

Topography of putaminal degeneration in multiple system atrophy: a diffusion magnetic resonance study.

1 reference

12 December 2020

Paroxetine treatment improves motor symptoms in patients with multiple system atrophy.

1 reference

12 December 2020

An autopsy case of early ("minimal change") olivopontocerebellar atrophy (multiple system atrophy-cerebellar).

1 reference

12 December 2020

Heredity in multiple system atrophy

1 reference

12 December 2020

Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's disease.

1 reference

12 December 2020

The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure

1 reference

12 December 2020

Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy

1 reference

12 December 2020

Multiple system atrophy: sporadic or familial?

1 reference

12 December 2020

The effects of water ingestion on orthostatic hypotension in two groups of chronic autonomic failure: multiple system atrophy and pure autonomic failure

1 reference

12 December 2020

Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy.

1 reference

12 December 2020

1 reference

12 December 2020

Prevention of glucose-induced hypotension by the somatostatin analogue octreotide (SMS 201-995) in chronic autonomic failure: haemodynamic and hormonal changes

1 reference

12 December 2020

Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes

1 reference

12 December 2020

Rasagiline is neuroprotective in a transgenic model of multiple system atrophy

1 reference

12 December 2020

Absence of alpha-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia.

1 reference

12 December 2020

Anatomically standardised 99mTc-ECD brain perfusion SPET allows accurate differentiation between healthy volunteers, multiple system atrophy and idiopathic Parkinson's disease

1 reference

12 December 2020

Microglial activation in multiple system atrophy: a potential role for NF-kappaB/rel proteins.

1 reference

12 December 2020

Distribution and dynamic process of neuronal cytoplasmic inclusion (NCI) in MSA: correlation of the density of NCI and the degree of involvement of the pontine nuclei.

1 reference

12 December 2020

The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations

1 reference

12 December 2020

The North American Multiple System Atrophy Study Group

1 reference

12 December 2020

Bilateral high-frequency stimulation of the subthalamic nucleus in patients with multiple system atrophy—parkinsonism

1 reference

12 December 2020

Comparison of brain MRI and 18F-FDG PET in the differential diagnosis of multiple system atrophy from Parkinson's disease

1 reference

12 December 2020

The fragile X tremor ataxia syndrome in the differential diagnosis of multiple system atrophy: data from the EMSA Study Group

1 reference

12 December 2020

Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration

1 reference

12 December 2020

1 reference

12 December 2020

The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: a correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems.

1 reference

12 December 2020

Statistical parametric mapping of (99m)Tc-ECD SPECT in idiopathic Parkinson's disease and multiple system atrophy with predominant parkinsonian features: correlation with clinical parameters.

1 reference

12 December 2020

Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse.

1 reference

12 December 2020

Increased survival of dopaminergic neurons by rasagiline, a monoamine oxidase B inhibitor.

1 reference

12 December 2020

Multiple system atrophy and progressive supranuclear palsy. Diminished striatal D2 dopamine receptor activity demonstrated by 123I-IBZM single photon emission computed tomography

1 reference

12 December 2020

The European Multiple System Atrophy-Study Group (EMSA-SG).

1 reference

12 December 2020

Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease

1 reference

12 December 2020

Contribution of the interleukin-1beta gene polymorphism in multiple system atrophy

1 reference

12 December 2020

Abnormal metabolic networks in atypical parkinsonism

1 reference

12 December 2020

Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure

1 reference

12 December 2020

Cellular pathology in multiple system atrophy

1 reference

12 December 2020

Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease

1 reference

12 December 2020

Associations between multiple system atrophy and polymorphisms of SLC1A4, SQSTM1, and EIF4EBP1 genes

1 reference

12 December 2020

Morphological substrate of autonomic failure and neurohormonal dysfunction in multiple system atrophy: impact on determining phenotype spectrum

1 reference

12 December 2020

Neuropathological spectrum of synucleinopathies

1 reference

12 December 2020

Medial pallidotomy in late-stage Parkinson's disease and striatonigral degeneration

1 reference

12 December 2020

Occupational therapy in multiple system atrophy: a pilot randomized controlled trial.

1 reference

12 December 2020

Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology

1 reference

12 December 2020

MRI derived brain atrophy in PSP and MSA-P. Determining sample size to detect treatment effects

1 reference

12 December 2020

Multiple system atrophy: alpha-synuclein and neuronal degeneration

1 reference

12 December 2020

Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients

1 reference

12 December 2020

Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients

1 reference

12 December 2020

Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P.

1 reference

12 December 2020

Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy

1 reference

12 December 2020

Apparent diffusion coefficient measurements of the middle cerebellar peduncle differentiate the Parkinson variant of MSA from Parkinson's disease and progressive supranuclear palsy.

1 reference

12 December 2020

Cell death mechanisms in multiple system atrophy.

1 reference

12 December 2020

Contrasting actions of pressor agents in severe autonomic failure

1 reference

12 December 2020

Risk factors of multiple system atrophy: a case-control study in French patients

1 reference

12 December 2020

Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions

1 reference

12 December 2020

Safety and tolerability of growth hormone therapy in multiple system atrophy: a double-blind, placebo-controlled study

1 reference

12 December 2020

Proposed neuroimaging criteria for the diagnosis of multiple system atrophy

1 reference

12 December 2020

Brain perfusion differences between Parkinson's disease and multiple system atrophy with predominant parkinsonian features.

1 reference

12 December 2020

Interleukin-8, intercellular adhesion molecule-1 and tumour necrosis factor-alpha gene polymorphisms and the risk for multiple system atrophy

1 reference

12 December 2020

Microglial activation mediates neurodegeneration related to oligodendroglial α-synucleinopathy: Implications for multiple system atrophy

1 reference

12 December 2020

Differentiation of atypical parkinsonian syndromes with routine MRI

1 reference

12 December 2020

Involvement of hypocretin neurons in multiple system atrophy.

1 reference

12 December 2020

The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology.

1 reference

12 December 2020

Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP.

1 reference

12 December 2020

Cigarette smoking and Parkinson's disease: A case-control study in a population characterized by a high prevalence of pesticide exposure

1 reference

12 December 2020

Diffusion-weighted imaging discriminates progressive supranuclear palsy from PD, but not from the parkinson variant of multiple system atrophy.

1 reference

12 December 2020

PET measurement of cardiac and nigrostriatal denervation in Parkinsonian syndromes.

1 reference

12 December 2020

Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism

1 reference

12 December 2020

The definition of multiple system atrophy: a review of recent developments

1 reference

12 December 2020

Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy.

1 reference

12 December 2020

SNCA variants are associated with increased risk for multiple system atrophy

1 reference

12 December 2020

Smoking habits in multiple system atrophy and progressive supranuclear palsy. European Study Group on Atypical Parkinsonisms

1 reference

12 December 2020

When is Onuf's nucleus involved in multiple system atrophy? A sphincter electromyography study

1 reference

12 December 2020

Dystonia in multiple system atrophy

1 reference

12 December 2020

Rasagiline and its (S) enantiomer increase survival and prevent stroke in salt-loaded stroke-prone spontaneously hypertensive rats

1 reference

12 December 2020

1 reference

12 December 2020

Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine

1 reference

12 December 2020

Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease.

1 reference

12 December 2020

Multiple system atrophy (MSA): topographic distribution of the alpha-synuclein-associated pathological changes.

1 reference

12 December 2020

Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystonia

1 reference

12 December 2020

Visualization and quantification of disease progression in multiple system atrophy.

1 reference

12 December 2020

1 reference

12 December 2020

Quantitative evaluation of brainstem involvement in multiple system atrophy by diffusion-weighted MR imaging

1 reference

12 December 2020

Neuropathological and behavioral changes induced by various treatment paradigms with MPTP and 3-nitropropionic acid in mice: towards a model of striatonigral degeneration (multiple system atrophy).

1 reference

12 December 2020

Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.

1 reference

12 December 2020

Influence of a tumor necrosis factor gene polymorphism in Japanese patients with multiple system atrophy.

1 reference

12 December 2020

Neuroprotective effect of rasagiline, a monoamine oxidase-B inhibitor, on spontaneous cell degeneration in a rat model

1 reference

12 December 2020

Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group

1 reference

12 December 2020

Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline.

1 reference

12 December 2020

Effects of the peptide release inhibitor, octreotide, on daytime hypotension and on nocturnal hypertension in primary autonomic failure

1 reference

12 December 2020

p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy

1 reference

12 December 2020

Brainstem in multiple system atrophy: clinicopathological correlations

1 reference

12 December 2020

Progression of brain atrophy in multiple system atrophy. A longitudinal VBM study.

1 reference

12 December 2020

Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein.

1 reference

12 December 2020

Man aged 49 years suffering from progressive clinical picture with palatal tremor, segmental myoclonus, ataxia, parkinsonism, amyotrophy, pyramidal signs, supranuclear ophthalmoplegia and cognitive decline

1 reference

12 December 2020

Clinical outcomes of progressive supranuclear palsy and multiple system atrophy

1 reference

12 December 2020

What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?

1 reference

12 December 2020

Transcranial sonography of the substantia nigra in Japanese patients with Parkinson's disease or atypical parkinsonism: clinical potential and limitations.

1 reference

12 December 2020

Longitudinal MRI in progressive supranuclear palsy and multiple system atrophy: rates and regions of atrophy.

1 reference

12 December 2020

Involvement of medullary serotonergic groups in multiple system atrophy

1 reference

12 December 2020

Reversal of behavioural abnormalities by fetal allografts in a novel rat model of striatonigral degeneration.

1 reference

12 December 2020

Potential outcome measures and trial design issues for multiple system atrophy

1 reference

12 December 2020

Genitourinary dysfunction in multiple system atrophy: clinical features and treatment in 62 cases

1 reference

12 December 2020

Interleukin-1A (-889) genetic polymorphism increases the risk of multiple system atrophy

1 reference

12 December 2020

Cortical metabolic changes in the cerebellar variant of multiple system atrophy: a voxel-based FDG-PET study in 41 patients.

1 reference

12 December 2020

The essentiality of Bcl-2, PKC and proteasome–ubiquitin complex activations in the neuroprotective-antiapoptotic action of the anti-Parkinson drug, rasagiline

1 reference

12 December 2020

Erectile and urinary dysfunction may be the presenting features in patients with multiple system atrophy: a retrospective study

1 reference

12 December 2020

Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability

1 reference

12 December 2020

Voxel-wise analysis of [123I]beta-CIT SPECT differentiates the Parkinson variant of multiple system atrophy from idiopathic Parkinson's disease

1 reference

12 December 2020

Multiple system atrophy: a sporadic synucleinopathy

1 reference

12 December 2020

The brain-specific protein TPPP/p25 in pathological protein deposits of neurodegenerative diseases

1 reference

12 December 2020

Consensus statement on the diagnosis of multiple system atrophy.

1 reference

12 December 2020

Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.

1 reference

12 December 2020

Non-invasive positive pressure ventilation for laryngeal contraction disorder during sleep in multiple system atrophy.

1 reference

12 December 2020

Cytoplasmic argyrophilic inclusions in neurons of pontine nuclei in patients with olivopontocerebellar atrophy: immunohistochemical and ultrastructural studies.

1 reference

12 December 2020

[123I]beta-CIT SPECT in multiple system atrophy, progressive supranuclear palsy, and corticobasal degeneration.

1 reference

12 December 2020

Neuronal cell loss of the striatonigral system in multiple system atrophy

1 reference

12 December 2020

Effects of pulsatile L-DOPA treatment in the double lesion rat model of striatonigral degeneration (multiple system atrophy).

1 reference

12 December 2020

Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy

1 reference

12 December 2020

Immunocytochemical and ultrastructural studies of neuronal and oligodendroglial cytoplasmic inclusions in multiple system atrophy. 1. Neuronal cytoplasmic inclusions

1 reference

12 December 2020

Animal models of multiple system atrophy.

1 reference

12 December 2020

Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy

1 reference

12 December 2020

p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies

1 reference

12 December 2020

alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy

1 reference

12 December 2020

Spatial patterns of alpha-synuclein positive glial cytoplasmic inclusions in multiple system atrophy

1 reference

12 December 2020

Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension

1 reference

12 December 2020

Multiple system atrophy--the nature of the beast

1 reference

12 December 2020

Multiple system atrophy

1 reference

12 December 2020

Striatal transplantation for multiple system atrophy--are grafts affected by alpha-synucleinopathy?

1 reference

12 December 2020

Progression and prognosis in multiple system atrophy: an analysis of 230 Japanese patients

1 reference

12 December 2020

Progression of parkinsonism in multiple system atrophy.

1 reference

12 December 2020

MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.

1 reference

12 December 2020

Olivopontocerebellar atrophy: toward a better nosological definition

1 reference

12 December 2020

Erythropoietin deficiency and anaemia in multiple system atrophy

1 reference

12 December 2020

[(123)I]beta-CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy

1 reference

12 December 2020

Epidemiology of multiple system atrophy: a prevalence and pilot risk factor study in Aquitaine, France

1 reference

12 December 2020

Signal changes on MRI and increases in reactive microgliosis, astrogliosis, and iron in the putamen of two patients with multiple system atrophy

1 reference

12 December 2020

Quantitative PCR-based screening of alpha-synuclein multiplication in multiple system atrophy

1 reference

12 December 2020

L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure

1 reference

12 December 2020

Quantitative simultaneous (99m)Tc-ECD/123I-FP-CIT SPECT in Parkinson's disease and multiple system atrophy

1 reference

12 December 2020

Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT

1 reference

12 December 2020

The clinical diagnosis of multiple system atrophy presenting as pure parkinsonism

1 reference

12 December 2020

A quantitative investigation of neuronal cytoplasmic and intranuclear inclusions in the pontine and inferior olivary nuclei in multiple system atrophy

1 reference

12 December 2020

Complex motor disturbances in a sequential double lesion rat model of striatonigral degeneration (multiple system atrophy)

1 reference

12 December 2020

Multiple system atrophy: a review of 203 pathologically proven cases

1 reference

12 December 2020

Sleep disorders in multiple system atrophy

1 reference

12 December 2020

Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis.

1 reference

12 December 2020

Frequency of nocturnal sudden death in patients with multiple system atrophy.

1 reference

12 December 2020

Macrogol 3350/electrolyte improves constipation in Parkinson's disease and multiple system atrophy.

1 reference

12 December 2020

Probable multiple system atrophy in a German family

1 reference

12 December 2020

Sporadic adult onset ataxia of unknown etiology : a clinical, electrophysiological and imaging study

1 reference

12 December 2020

10.1007/S00415-009-5173-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19471850%20AND%20SRC:MED&resulttype=core&format=json

release_qnvgax5eizb7nnueuaceph2wwa

29 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qnvgax5eizb7nnueuaceph2wwa

24 November 2022

mapped directly with Wikidata item

1 reference